Sequential outpatient application intravaginal prostaglandin gel management postdates pregnancies randomized investigation efficacy safety intravaginal prostaglandin gel cervical ripening outpatient setting low-risk prolonged pregnancies Fifty women uncomplicated pregnancies weeks gestation Bishop twice-weekly outpatient administration gel mg placebo Thirty nulliparas multiparas gel cervical ripening placebo Bishop scores difference groups gestational age admission labor delivery suite number gel applications requirement oxytocin incidence cesarean delivery neonatal outcome patients regular uterine contractions gel insertion None subjects labor tetanic contractions evidence fetal distress side effects insertion gel dosage outpatient setting frequent application initiation clinical effect 